MX2020006191A - Bacteriocinas terapeuticas. - Google Patents
Bacteriocinas terapeuticas.Info
- Publication number
- MX2020006191A MX2020006191A MX2020006191A MX2020006191A MX2020006191A MX 2020006191 A MX2020006191 A MX 2020006191A MX 2020006191 A MX2020006191 A MX 2020006191A MX 2020006191 A MX2020006191 A MX 2020006191A MX 2020006191 A MX2020006191 A MX 2020006191A
- Authority
- MX
- Mexico
- Prior art keywords
- bacteriocins
- therapeutic
- compositions
- methods
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/10—Animals; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/26—Klebsiella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención proporciona métodos y composiciones para reducir el crecimiento de colonias microbianas, incluyendo infecciones e incluye composiciones terapéuticas, métodos para el tratamiento de infecciones y métodos para identificar esas composiciones adicionales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201741045069 | 2017-12-14 | ||
PCT/IN2018/050837 WO2019116392A1 (en) | 2017-12-14 | 2018-12-13 | Therapeutic bacteriocins |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020006191A true MX2020006191A (es) | 2020-11-06 |
Family
ID=66819621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020006191A MX2020006191A (es) | 2017-12-14 | 2018-12-13 | Bacteriocinas terapeuticas. |
Country Status (7)
Country | Link |
---|---|
US (1) | US11857606B2 (es) |
EP (1) | EP3723488A4 (es) |
JP (1) | JP7465418B2 (es) |
CN (1) | CN111770687A (es) |
CA (1) | CA3085697A1 (es) |
MX (1) | MX2020006191A (es) |
WO (1) | WO2019116392A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3378485A1 (en) * | 2017-03-24 | 2018-09-26 | Nomad Bioscience GmbH | Bacteriocins for control of salmonella enterica |
CA3085697A1 (en) * | 2017-12-14 | 2019-06-20 | Bactoclear Holdings Pte Ltd. | Therapeutic bacteriocins |
EP3873917A4 (en) * | 2018-11-02 | 2022-08-17 | The Rockefeller University | COMPOSITIONS AND METHODS COMPRISING LYSOCINES AS BIOTECHNICAL ANTIMICROBIAL FOR USE IN TARGETING GRAM-NEGATIVE BACTERIA |
GB202109082D0 (en) * | 2021-06-24 | 2021-08-11 | Univ Oxford Innovation Ltd | Polypeptides and uses thereof |
EP4370533A2 (en) * | 2021-07-12 | 2024-05-22 | Bactoclear Holdings Pte. Ltd. | Chimeric klebicins |
EP4248987A1 (en) * | 2022-03-21 | 2023-09-27 | Nomad Bioscience GmbH | Chimeric bacteriocins and method for the control of pseudomonas |
WO2023230745A1 (zh) * | 2022-05-30 | 2023-12-07 | 中国科学院深圳先进技术研究院 | 一种生产靶向治疗活性成分的可生成细菌纤维素工程菌及其制备方法 |
WO2023239814A1 (en) * | 2022-06-07 | 2023-12-14 | University Of Cincinnati | Epitope-independent pretargeted therapy of cancers using bacteria |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700729B2 (en) | 2006-05-15 | 2010-04-20 | Avidbiotics Corporation | Modified bacteriocins and methods for their use |
US8445639B2 (en) | 2006-05-15 | 2013-05-21 | Avidbiotics Corporation | Recombinant bacteriophage and methods for their use |
US20110311499A1 (en) * | 2009-12-16 | 2011-12-22 | University Of Washington Through Its Center For Commercialization | Secretion System and Methods for its Use |
MX347771B (es) | 2011-04-12 | 2017-05-12 | Gangagen Inc | Polipeptidos antibacterianos quimericos. |
GB201416788D0 (en) * | 2014-09-23 | 2014-11-05 | Univ Glasgow | Therapeutic applications for pyocins |
CA3085697A1 (en) * | 2017-12-14 | 2019-06-20 | Bactoclear Holdings Pte Ltd. | Therapeutic bacteriocins |
-
2018
- 2018-12-13 CA CA3085697A patent/CA3085697A1/en active Pending
- 2018-12-13 CN CN201880088446.0A patent/CN111770687A/zh active Pending
- 2018-12-13 JP JP2020552184A patent/JP7465418B2/ja active Active
- 2018-12-13 WO PCT/IN2018/050837 patent/WO2019116392A1/en unknown
- 2018-12-13 US US16/954,120 patent/US11857606B2/en active Active
- 2018-12-13 EP EP18889717.7A patent/EP3723488A4/en active Pending
- 2018-12-13 MX MX2020006191A patent/MX2020006191A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN111770687A (zh) | 2020-10-13 |
EP3723488A4 (en) | 2021-10-20 |
JP7465418B2 (ja) | 2024-04-11 |
EP3723488A1 (en) | 2020-10-21 |
JP2021506341A (ja) | 2021-02-22 |
US11857606B2 (en) | 2024-01-02 |
CA3085697A1 (en) | 2019-06-20 |
WO2019116392A1 (en) | 2019-06-20 |
US20210163546A1 (en) | 2021-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020006191A (es) | Bacteriocinas terapeuticas. | |
MX2017014020A (es) | Terapia antimicrobiana. | |
EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
MX2022000056A (es) | Peptidos anti-microbianos estabilizados. | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
EA201891199A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891202A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890048A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890047A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
PH12017501646A1 (en) | Antimicrobial compounds and methods of making and using the same | |
MX2019007613A (es) | Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos. | |
CR20190537A (es) | Inhibidores pirazólicos de magl | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
MX2020004118A (es) | Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas. | |
MX2020009736A (es) | Composiciones que comprenden cepas bacterianas. | |
WO2019178487A3 (en) | Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae | |
ZA202002093B (en) | Antibacterial compounds | |
MY200161A (en) | Bacteria for targeting tumors and treating cancer | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. |